<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35412848</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-9102</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of speech, language, and hearing research : JSLHR</Title><ISOAbbreviation>J Speech Lang Hear Res</ISOAbbreviation></Journal><ArticleTitle>Acoustic Change Over Time in Spastic and/or Flaccid Dysarthria in Motor Neuron Diseases.</ArticleTitle><Pagination><StartPage>1767</StartPage><EndPage>1783</EndPage><MedlinePgn>1767-1783</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1044/2022_JSLHR-21-00434</ELocationID><Abstract><AbstractText Label="PURPOSE">This study aims to investigate acoustic change over time as biomarkers to differentiate among spastic-flaccid dysarthria associated with amyotrophic lateral sclerosis (ALS), spastic dysarthria associated with primary lateral sclerosis (PLS), flaccid dysarthria associated with spinal and bulbar muscular atrophy (SBMA), and to explore how these acoustic parameters are affected by dysarthria severity.</AbstractText><AbstractText Label="METHOD">Thirty-three ALS patients with mixed flaccid-spastic dysarthria, 17 PLS patients with pure spastic dysarthria, 18 SBMA patients with pure flaccid dysarthria, and 70 controls, all French speakers, were included in the study. Speakers produced vowel-glide sequences targeting different vocal tract shape changes. The mean and coefficient of variation of the total squared change of mel frequency cepstral coefficients were used to capture the degree and variability of acoustic changes linked to vocal tract modifications over time. Differences in duration of acoustic events were also measured.</AbstractText><AbstractText Label="RESULTS">All pathological groups showed significantly less acoustic change compared to controls, reflecting less acoustic contrast in sequences. Spastic and mixed spastic-flaccid dysarthric speakers showed smaller acoustic changes and slower sequence production compared to flaccid dysarthria. For dysarthria subtypes associated with a spastic component, reduced degree of acoustic change was also associated with dysarthria severity.</AbstractText><AbstractText Label="CONCLUSIONS">The acoustic parameters partially differentiated among the dysarthria subtypes in relation to motor neuron diseases. While similar acoustic patterns were found in spastic-flaccid and spastic dysarthria, crucial differences were found between these two subtypes relating to variability. The acoustic patterns were much more variable in ALS. This method forms a promising clinical tool as a diagnostic marker of articulatory impairment, even at mild stage of dysarthria progression in all subtypes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>L&#xe9;v&#xea;que</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-6409-1923</Identifier><AffiliationInfo><Affiliation>Laboratoire de Phon&#xe9;tique et de Phonologie, UMR 7018, CNRS/University Sorbonne-Nouvelle, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Assistance Publique - H&#xf4;pitaux de Paris, Department of Neurology, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, ALS Reference Center, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slis</LastName><ForeName>Anneke</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1192-5848</Identifier><AffiliationInfo><Affiliation>Laboratoire de Phon&#xe9;tique et de Phonologie, UMR 7018, CNRS/University Sorbonne-Nouvelle, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lancia</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratoire de Phon&#xe9;tique et de Phonologie, UMR 7018, CNRS/University Sorbonne-Nouvelle, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruneteau</LastName><ForeName>Ga&#xeb;lle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Assistance Publique - H&#xf4;pitaux de Paris, Department of Neurology, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, ALS Reference Center, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fougeron</LastName><ForeName>C&#xe9;cile</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratoire de Phon&#xe9;tique et de Phonologie, UMR 7018, CNRS/University Sorbonne-Nouvelle, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Speech Lang Hear Res</MedlineTA><NlmUniqueID>9705610</NlmUniqueID><ISSNLinking>1092-4388</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000162" MajorTopicYN="N">Acoustics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004401" MajorTopicYN="N">Dysarthria</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009128" MajorTopicYN="N">Muscle Spasticity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013061" MajorTopicYN="N">Speech Acoustics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013065" MajorTopicYN="N">Speech Intelligibility</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>17</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35412848</ArticleId><ArticleId IdType="doi">10.1044/2022_JSLHR-21-00434</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>